Max Healthcare Institute Limited Stock Price Today (NSE: MAXHEALTH)
Fundamental Score
Max Healthcare Institute Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Max Healthcare Institute Limited share price today is ₹1014.40, up +0.58% on NSE/BSE as of 21 August 2026. Max Healthcare Institute Limited (MAXHEALTH) is a Large-cap company in the Hospital sector with a market capitalisation of ₹1.07L (Cr). The 52-week high for MAXHEALTH share price is ₹1252.50 and the 52-week low is ₹903.00. At a P/E ratio of 72.42x, MAXHEALTH is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 14.74% and a debt-to-equity ratio of 0.32.
Max Healthcare Institute Limited Share Price Chart — NSE/BSE Historical Performance
Max Healthcare Institute Limited share price chart: -7.36% return over the past month. 52-week high ₹1252.50, 52-week low ₹903.00.
Max Healthcare Institute Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1000.70 | ₹1017.00 | ₹982.10 | ₹1014.40 | 22.19L (Cr) | |
| ₹1013.30 | ₹1017.90 | ₹981.10 | ₹1008.60 | 40.52L (Cr) | |
| ₹1007.90 | ₹1037.60 | ₹992.80 | ₹1013.30 | 28.71L (Cr) | |
| ₹1030.80 | ₹1034.90 | ₹1001.50 | ₹1007.50 | 27.62L (Cr) | |
| ₹1065.40 | ₹1067.40 | ₹1034.70 | ₹1040.00 | 28.92L (Cr) | |
| ₹1070.20 | ₹1079.90 | ₹1054.30 | ₹1069.00 | 21.25L (Cr) | |
| ₹1070.00 | ₹1084.30 | ₹1067.00 | ₹1070.00 | 11.90L (Cr) | |
| ₹1079.50 | ₹1079.50 | ₹1064.10 | ₹1072.40 | 17.29L (Cr) | |
| ₹1080.00 | ₹1087.00 | ₹1066.40 | ₹1080.00 | 11.71L (Cr) | |
| ₹1105.10 | ₹1105.10 | ₹1066.10 | ₹1077.00 | 14.92L (Cr) |
Max Healthcare Institute Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1109.80 | ₹1113.90 | ₹981.10 | ₹1014.40 | -8.60% | |
| ₹1134.90 | ₹1167.90 | ₹1068.80 | ₹1098.50 | -3.21% | |
| ₹970.00 | ₹1159.00 | ₹919.80 | ₹1129.25 | +16.42% | |
| ₹993.05 | ₹1111.00 | ₹955.00 | ₹965.10 | -2.81% | |
| ₹966.20 | ₹1029.10 | ₹903.00 | ₹993.05 | +2.78% | |
| ₹1056.50 | ₹1088.40 | ₹937.30 | ₹962.30 | -8.92% | |
| ₹980.00 | ₹1112.55 | ₹933.80 | ₹1091.95 | +11.42% | |
| ₹1048.20 | ₹1064.40 | ₹940.00 | ₹956.80 | -8.72% | |
| ₹1164.00 | ₹1167.40 | ₹1024.90 | ₹1045.10 | -10.21% | |
| ₹1146.70 | ₹1185.40 | ₹1075.10 | ₹1162.80 | +1.40% | |
| ₹1119.70 | ₹1221.90 | ₹1060.00 | ₹1147.80 | +2.51% | |
| ₹1154.30 | ₹1189.00 | ₹1107.00 | ₹1114.70 | -3.43% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Max Healthcare Institute Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Max Healthcare Institute Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MAXHEALTH across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (26.53%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (27.27% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (59.77% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (60.01% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (8.33x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹2076.63 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 71.71%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 72.42x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (10.51x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Liquidity Concerns (Current Ratio: 0.88)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Low Promoter Commitment (23.71%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Max Healthcare Institute Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Max Healthcare Institute Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Max Healthcare Institute LimitedMax Healthcare ...Selected✓ MAXHEALTH • 543220 | 56.9/100 | ₹1014.40₹1014 | ₹107422.79₹107422.79 | 72.42Average 72.4 Average | 14.74%Average 14.74% Average | 14.71%Average 14.71% Average | 0.32Excellent 0.3 Excellent | 60.01%Excellent 60.01% Excellent | 27.27%Excellent 27.27% Excellent | 0.18% |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 48.5/100 | ₹480.05₹480 | ₹15618.15₹15618.15 | 117.89Average 117.9 Average | 6.81%Poor 6.81% Poor | 11.12%Average 11.12% Average | 0.53Good 0.5 Good | 34.42%Excellent 34.42% Excellent | 34.58%Excellent 34.58% Excellent | 0.00% |
Yatharth Hospital & Trauma Care Services LtdYatharth Hospit... YATHARTH • 543950 | 53/100 | ₹812.95₹813 | ₹8100.43₹8100.43 | 46.19Average 46.2 Average | 10.36%Average 10.36% Average | 12.37%Average 12.37% Average | 0.15Excellent 0.1 Excellent | 57.39%Excellent 57.39% Excellent | 41.18%Excellent 41.18% Excellent | 0.00% |
Artemis Medicare Services LtdArtemis Medicar... ARTEMISMED • 542919 | 69.5/100 | ₹273.45₹273 | ₹4376.46₹4376.46 | 41.39Average 41.4 Average | 11.88%Average 11.88% Average | 14.53%Average 14.53% Average | 0.28Excellent 0.3 Excellent | 75.56%Excellent 75.56% Excellent | 21.41%Excellent 21.41% Excellent | 0.16% |
Unihealth Hospitals LtdUnihealth Hospi... UNIHEALTH • | 65.8/100 | ₹717.00₹717 | ₹1123.65₹1123.65 | 43.83Average 43.8 Average | 21.46%Excellent 21.46% Excellent | 24.48%Excellent 24.48% Excellent | 0.24Excellent 0.2 Excellent | 38.61%Excellent 38.61% Excellent | 38.17%Excellent 38.17% Excellent | 0.00% |
Aashka Hospitals LtdAashka Hospital... AASHKA • 543346 | 36.5/100 | ₹73.00₹73 | ₹191.65₹191.65 | 67.48Average 67.5 Average | 2.80%Poor 2.80% Poor | 4.05%Poor 4.05% Poor | 0.08Excellent 0.1 Excellent | -7.13%Poor -7.13% Poor | -10.78%Poor -10.78% Poor | 0.00% |
Abateas Industries LtdAbateas Industr... ABATEAS • 531658 | 34.4/100 | ₹9.71₹10 | ₹155.55₹155.55 | 12.65Average 12.7 Average | 7.30%Poor 7.30% Poor | 6.70%Poor 6.70% Poor | 0.06Excellent 0.1 Excellent | — — | — — | 0.00% |
Nephro Care India LimitedNephro Care Ind... NEPHROCARE • | 45.4/100 | ₹65.40₹65 | ₹108.73₹108.73 | 32.26Average 32.3 Average | 6.11%Poor 6.11% Poor | 8.70%Poor 8.70% Poor | 0.00Excellent 0.0 Excellent | 106.38%Excellent 106.38% Excellent | 117.57%Excellent 117.57% Excellent | 0.00% |
MAITREYA MEDICAREMAITREYA MEDICA... MAITREYA • | 6.9/100 | ₹132.60₹133 | ₹83.34₹83.34 | — — | -8.86%Poor -8.86% Poor | -2.18%Poor -2.18% Poor | 0.80Good 0.8 Good | — — | -4.32%Poor -4.32% Poor | 0.00% |
SANGANI HOSPITALSSANGANI HOSPITA... SANGANI • | 53.4/100 | ₹42.70₹43 | ₹61.86₹61.86 | 20.69Average 20.7 Average | 7.76%Poor 7.76% Poor | 17.37%Good 17.37% Good | 0.04Excellent 0.0 Excellent | — — | — — | 0.00% |
31/100 | ₹17.75₹18 | ₹43.73₹43.73 | 61.59Average 61.6 Average | 1.41%Poor 1.41% Poor | 3.56%Poor 3.56% Poor | 0.41Excellent 0.4 Excellent | -29.65%Poor -29.65% Poor | 9.44%Good 9.44% Good | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
Max Healthcare Institute Limited PE Ratio History
Historical price-to-earnings ratio for MAXHEALTH — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹11.01 | ₹1045.10 | 94.9x |
| FY 2024 | ₹10.84 | ₹1128.15 | 104.1x |
| FY 2023 | ₹11.36 | ₹686.25 | 60.4x |
| FY 2022 | ₹6.24 | ₹439.55 | 70.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Max Healthcare Institute Limited Dividend History
Annual cash dividends paid by MAXHEALTH — dividend yield 0.18%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹145.58 Cr |
| FY 2024 | ₹97.01 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Max Healthcare Institute Limited Quarterly Performance
Latest quarterly metrics for MAXHEALTH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
12.21%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
7.28%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
27.27%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
60.01%
Compounded annual net profit growth over 5 years
Max Healthcare Institute Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MAXHEALTH — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Max Healthcare Institute Limited Financial Statements
Annual income statement, balance sheet and cash flow for Max Healthcare Institute Limited (MAXHEALTH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Max Healthcare Institute Limited
About MAXHEALTH (Max Healthcare Institute Limited)
Max Healthcare Institute Ltd is a prominent healthcare provider in India, distinguished by its commitment to delivering advanced medical care across a wide spectrum of specialties.... Housing state-of-the-art facilities and a team of highly skilled medical professionals, Max Healthcare stands as a beacon of hope and healing for patients seeking world-class treatment. Its comprehensive services encompass both inpatient and outpatient care, ensuring that individuals receive personalized attention and the best possible outcomes. Dedicated to innovation and patient-centricity, Max Healthcare strives to redefine healthcare standards in India and beyond, offering a holistic approach that addresses the physical, emotional, and mental well-being of its patients. The hospital's expansive range of services extends to critical and complex medical areas, including cardiac care, bone and joint replacements, cancer treatment, and neurological disorders. The institute provides specialized care in other fields, like kidney ailments, digestive system issues, and disorders of the respiratory system, reflecting its dedication to addressing diverse healthcare requirements. Max Healthcare's expertise also covers women's health, children's health, and the intricate domain of organ transplantation, signifying its capability to manage life-altering medical challenges. Each department integrates cutting-edge technology with evidence-based practices, establishing Max Healthcare as a preferred choice for patients seeking specialized and reliable medical intervention. Beyond its advanced clinical services, Max Healthcare also provides alternative models to deliver care. It offers Max@Home, a service designed to extend quality healthcare beyond the confines of the hospital. This program offers medical attention in the comfort of a patient's home, catering to individuals who require ongoing care, elderly patients, or those with mobility challenges. This initiative underscores Max Healthcare's dedication to providing easily accessible, patient-focused healthcare solutions, bridging the gap between hospital-based treatment and continuing well-being.
Company Details
Key Leadership
Corporate Events
MAXHEALTH Share Price: Frequently Asked Questions
What is the current share price of Max Healthcare Institute Limited?
Max Healthcare Institute Limited (MAXHEALTH) trades at ₹1014.40 on NSE and BSE. Market cap ₹1.07L (Cr). Educational data only.
What is the P/E ratio of Max Healthcare Institute Limited?
Max Healthcare Institute Limited has a P/E of 72.42x vs industry average 48.79x.
What is the Bull Run score for Max Healthcare Institute Limited?
Max Healthcare Institute Limited has a Bull Run score of 56.9/100 based on 25+ financial parameters.
Does Max Healthcare Institute Limited pay dividends?
Max Healthcare Institute Limited has a dividend yield of 0.18%. Past dividends don't guarantee future payments.
What is the ROE of Max Healthcare Institute Limited?
Max Healthcare Institute Limited has ROE of 14.74%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Max Healthcare Institute Limited?
Max Healthcare Institute Limited has debt-to-equity of 0.32.
Is Max Healthcare Institute Limited a good investment?
Bull Run gives Max Healthcare Institute Limited a score of 56.9/100. This is not investment advice — consult a SEBI-registered advisor.